UHS considers funding HPV shot
Yale’s chapter of Colleges Against Cancer will begin a petition drive this week to encourage the University to cover the cost of the recently approved vaccine against human papillomavirus.
The vaccine, called Gardasil, was approved by the FDA in June 2006 as the first vaccine that protects against cervical cancer, precancerous lesions and genital warts caused by four types of HPV, the most common sexually-transmitted infection in the U.S. After the federal government recommended that all preteen girls be vaccinated against the virus, dozens of states introduced legislation that...
Sorry, but comments are disabled for this article.